Loading data for HQL — first visit, this takes a few seconds.
Abrdn Life Sciences Investors (HQL)
NYSE: HQL
· 实时价格 · USD
20.98
+0.11 (0.53%)
收盘价： Sep 08, 2026, 1:36 PM
股价、关键数字和最新消息，都在这一页。
Abrdn Life Sciences Investors（HQL）股价、分析与数据
暂无数据
| 买价 | 20.89 |
| 市值 | 622M |
| 营收（TTM） | 1.11M |
| 净利润（TTM） | 198M |
| 0.72 | |
| 6.64 | |
| 3.08 | |
| n/a | |
| 市净率（TTM） | 1.11 |
| 市销率（TTM） | 560.89 |
| 财报日期 | n/a |
| 卖价 | 20.95 |
| 成交量 | 141,130 |
| 20日均量 | 149,803 |
| 开盘价 | 20.96 |
| 前收盘价 | 20.87 |
| 日内区间 | 20.73 - 21.43 |
| 52周区间 | 13.88 - 22.67 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | $2.24 (10.85%) |
| 除息日 | Aug 24, 2026 |
关于 HQL
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture...
公司完整简介财报意外
Abrdn Life Sciences Investors 已于 Invalid Date 发布季度财报：
- 营收为 n/a 低于预期 $0, ， NaN% 同比增长.
- 每股收益为 低于预期 , ， NaN% 同比增长.